NICE-CIBERNED: Clinical and Experimental Neuroscience
Pitié-Salpêtrière Hospital
París, FranciaPublications in collaboration with researchers from Pitié-Salpêtrière Hospital (35)
2016
-
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
Acta Neuropathologica Communications, Vol. 4, Núm. 1
-
Sorting the good from the bad: The different approaches to predict cognitive properties of new symptomatic drug candidates for neurodegenerative diseases in early development
CNS and Neurological Disorders - Drug Targets
2015
-
Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with alzheimer-like Tau pathology
Human Molecular Genetics, Vol. 24, Núm. 21, pp. 5965-5976
2013
-
Evaluation of symptomatic drug effects in Alzheimer's disease: Strategies for prediction of efficacy in humans
Drug Discovery Today: Technologies, Vol. 10, Núm. 3
2012
-
Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S
Journal of Alzheimer's Disease, Vol. 31, Núm. 4, pp. 741-749
2011
-
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 16, pp. 6632-6637
2009
-
Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication
Journal of Neurochemistry, Vol. 110, Núm. 4, pp. 1321-1329
2008
-
Increased mRNA expression of cytochrome oxidase in dorsal raphe nucleus of depressive suicide victims
Neuropsychiatric Disease and Treatment, Vol. 4, Núm. 2, pp. 413-416
2007
-
Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism
Brain, Vol. 130, Núm. 1, pp. 265-275
2005
-
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
Journal of Neural Transmission, Vol. 112, Núm. 9, pp. 1237-1248
2004
-
Blood vessels and parkinsonism
Frontiers in Bioscience, Vol. 9, pp. 277-282
-
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
GLIA, Vol. 46, Núm. 4, pp. 402-409
2000
-
Metabolic effects of nigrostriatal denervation in basal ganglia
Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.
1998
-
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys
Experimental Neurology, Vol. 154, Núm. 1, pp. 146-156
1997
-
Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA
Journal of Neuroscience, Vol. 17, Núm. 2, pp. 765-773
-
Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders
Journal of Neurochemistry, Vol. 69, Núm. 1, pp. 223-231
-
Neurochemical correlates of parkinsonism. Role of dopaminergic lesions.
Advances in neurology, Vol. 74, pp. 119-126
-
Re-evaluation of the functional anatomy of the basal ganglia. In normal and Parkinsonian states
Neuroscience
1996
-
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum
Neurology, Vol. 47, Núm. 1, pp. 219-224
-
Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes
Neurology, Vol. 46, Núm. 3, pp. 802-809